Molecular and clinical assessment in the treatment of AIDS Kaposi sarcoma with valproic Acid.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 19911999.
- Also identified by DOI 10.1086/648447 and PMC identifier 2952388.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The AIDS Malignancy Consortium undertook a pilot trial of valproic acid among patients with AIDS-associated Kaposi sarcoma (KS). Treatment was associated with low toxicity, but the KS clinical response and KS herpesvirus lytic induction rates were not sufficiently high to meet predefined criteria for efficacy.
Medical subject headings
- Acquired Immunodeficiency Syndrome
- Sarcoma, Kaposi
- Valproic Acid